We are live on ! Find out more
VYNT

Vyant Bio, Inc. Common Stock
VYNT

Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

1 hedge funds and large institutions have $1 invested in Vyant Bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% less funds holding

Funds holding: 17 → 1 (-16)

100% less capital invested

Capital invested by funds: $137K → $1 (-$137K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 16

Holders
1
Holders Change
-16
Holders Change %
-94.12%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$27.4K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$22.5K
3
MC
Mayo Clinic
Minnesota
-$16.1K
4
BlackRock
BlackRock
New York
-$15.4K
5
Millennium Management
Millennium Management
New York
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
1
Barclays
United Kingdom
$1 – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$27.4K -47,256 Closed
Geode Capital Management
3
Geode Capital Management
Massachusetts
– -$22.5K -38,820 Closed
MC
4
Mayo Clinic
Minnesota
– -$16.1K -27,742 Closed
BlackRock
5
BlackRock
New York
– -$15.4K -26,558 Closed
Millennium Management
6
Millennium Management
New York
– -$13K -22,419 Closed
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
– -$11.6K -20,001 Closed
State Street
8
State Street
Massachusetts
– -$8.72K -15,038 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
– -$8K -13,820 Closed
VF
10
Virtu Financial
New York
– -$7K -12,521 Closed
UBS Group
11
UBS Group
Switzerland
– -$3.17K -5,463 Closed
US Bancorp
12
US Bancorp
Minnesota
– -$2.88K -4,962 Closed
TRCT
13
Tower Research Capital (TRC)
New York
– -$1K -2,478 Closed
Wells Fargo
14
Wells Fargo
California
– -$18 -31 Closed
Osaic Holdings
15
Osaic Holdings
Arizona
– -$14 -24 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$5 -9 Closed

VYNT Hedge Fund Activity: Q2 2023 in Review

1 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q2 2023, worth a combined $1 — down 100% from $137K a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of VYNT and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $27.4K sold.

  • 1 institutional investor held Vyant Bio, Inc. Common Stock (VYNT) as of Q2 2023, down from 17 in Q1 2023.
  • Funds reported $1 of Vyant Bio, Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Vyant Bio, Inc. Common Stock positions in Q2 2023 and 16 closed out, a net change of -16 holders.
  • The largest Vyant Bio, Inc. Common Stock seller in Q2 2023 was Vanguard Group, an estimated $27.4K sold.

Based on aggregated 13F filings for Q2 2023.